Cargando…
1419. 24-Hour Pharmacokinetic Relationships for Intravenous Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury
BACKGROUND: Vancomycin induces exposure-related acute kidney injury; yet only troughs are generally monitored in patients. In rat models, intraperitoneal dosing results in highly variable drug exposures. Thus, intravenous (IV) vancomycin was used to assess pharmacokinetic-toxicodynamic (PK-TD) relat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254309/ http://dx.doi.org/10.1093/ofid/ofy210.1250 |
_version_ | 1783373693749035008 |
---|---|
author | Avedissian, Sean Liu, Jiajun O’Donnell, J Nicholas Pais, Gwendolyn Becher, Leighton Joshi, Medha Prozialeck, Walter Lamar, Peter Lodise, Thomas P Scheetz, Marc H |
author_facet | Avedissian, Sean Liu, Jiajun O’Donnell, J Nicholas Pais, Gwendolyn Becher, Leighton Joshi, Medha Prozialeck, Walter Lamar, Peter Lodise, Thomas P Scheetz, Marc H |
author_sort | Avedissian, Sean |
collection | PubMed |
description | BACKGROUND: Vancomycin induces exposure-related acute kidney injury; yet only troughs are generally monitored in patients. In rat models, intraperitoneal dosing results in highly variable drug exposures. Thus, intravenous (IV) vancomycin was used to assess pharmacokinetic-toxicodynamic (PK-TD) relationships with nephrotoxicity. METHODS: Male Sprague-Dawley rats received IV vancomycin via an internal jugular vein catheter. Total daily doses ranging from 150 to 400 mg/kg/day were administered as a single or twice daily injection over 24 hours. Controls received IV saline. Plasma sampling was conducted via a second dedicated catheter, with up to eight samples in 24 hours. Twenty-four-hour urine was collected during this time and assayed for kidney injury molecule 1 (KIM-1), osteopontin (OPN) and clusterin using the MILLIPLEX MAP Rat Kidney Panel. Vancomycin in plasma was quantified via LC–MS/MS. PK analyses were conducted using Pmetrics for R. PK exposures during the first 24 hours (i.e., AUC(0–24), C(MAX0–24), C(MIN0–24)) were calculated from Bayesian posteriors. PK-TD relationships were assessed with Spearman’s rank coefficient (r(s)) and the best fit mathematic model (e.g., exposure response curve fitting in GraphPad v.7). RESULTS: Forty-five vancomycin treated and five control rats contributed PK-TD data. A two-compartment model fit the data well (Figure 1: Population [a], Individual [b]). An exposure-response relationship was found between AUC(0–24) vs. KIM-1 (Figure 2a) and osteopontin (Figure 3a) and C(MAX24) vs. KIM-1 (Figure 2b) and osteopontin (Figure 3b) by four-parameter Hill fit. A weaker relationship was found for CMIN(0–24 hours) vs. KIM-1 (R(2) = 0.46) and less parity existed between PK measures and osteopontin, though AUC24 was best (R(2) = 0.66), all by four-parameter Hill fits. Spearman’s r(s) showed significant correlations between AUC(0–24) vs. KIM-1, AUC(0–24) vs. osteopontin and C(MAX0–24) vs. osteopontin (P < 0.001, r(s) = 0.53, r(s) = 0.75, r(s) = 0.65). CONCLUSION: Vancomycin induced kidney injury is most driven by AUC or C(MAX). Clinical monitoring should focus on C(MAX) and AUC and move away from trough only sampling. [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: J. Liu, Merck: Grant fund from Merck, Research grant. W. Prozialeck, Midwetsren University: Collaborator, Grant recipient. |
format | Online Article Text |
id | pubmed-6254309 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62543092018-11-28 1419. 24-Hour Pharmacokinetic Relationships for Intravenous Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury Avedissian, Sean Liu, Jiajun O’Donnell, J Nicholas Pais, Gwendolyn Becher, Leighton Joshi, Medha Prozialeck, Walter Lamar, Peter Lodise, Thomas P Scheetz, Marc H Open Forum Infect Dis Abstracts BACKGROUND: Vancomycin induces exposure-related acute kidney injury; yet only troughs are generally monitored in patients. In rat models, intraperitoneal dosing results in highly variable drug exposures. Thus, intravenous (IV) vancomycin was used to assess pharmacokinetic-toxicodynamic (PK-TD) relationships with nephrotoxicity. METHODS: Male Sprague-Dawley rats received IV vancomycin via an internal jugular vein catheter. Total daily doses ranging from 150 to 400 mg/kg/day were administered as a single or twice daily injection over 24 hours. Controls received IV saline. Plasma sampling was conducted via a second dedicated catheter, with up to eight samples in 24 hours. Twenty-four-hour urine was collected during this time and assayed for kidney injury molecule 1 (KIM-1), osteopontin (OPN) and clusterin using the MILLIPLEX MAP Rat Kidney Panel. Vancomycin in plasma was quantified via LC–MS/MS. PK analyses were conducted using Pmetrics for R. PK exposures during the first 24 hours (i.e., AUC(0–24), C(MAX0–24), C(MIN0–24)) were calculated from Bayesian posteriors. PK-TD relationships were assessed with Spearman’s rank coefficient (r(s)) and the best fit mathematic model (e.g., exposure response curve fitting in GraphPad v.7). RESULTS: Forty-five vancomycin treated and five control rats contributed PK-TD data. A two-compartment model fit the data well (Figure 1: Population [a], Individual [b]). An exposure-response relationship was found between AUC(0–24) vs. KIM-1 (Figure 2a) and osteopontin (Figure 3a) and C(MAX24) vs. KIM-1 (Figure 2b) and osteopontin (Figure 3b) by four-parameter Hill fit. A weaker relationship was found for CMIN(0–24 hours) vs. KIM-1 (R(2) = 0.46) and less parity existed between PK measures and osteopontin, though AUC24 was best (R(2) = 0.66), all by four-parameter Hill fits. Spearman’s r(s) showed significant correlations between AUC(0–24) vs. KIM-1, AUC(0–24) vs. osteopontin and C(MAX0–24) vs. osteopontin (P < 0.001, r(s) = 0.53, r(s) = 0.75, r(s) = 0.65). CONCLUSION: Vancomycin induced kidney injury is most driven by AUC or C(MAX). Clinical monitoring should focus on C(MAX) and AUC and move away from trough only sampling. [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: J. Liu, Merck: Grant fund from Merck, Research grant. W. Prozialeck, Midwetsren University: Collaborator, Grant recipient. Oxford University Press 2018-11-26 /pmc/articles/PMC6254309/ http://dx.doi.org/10.1093/ofid/ofy210.1250 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Avedissian, Sean Liu, Jiajun O’Donnell, J Nicholas Pais, Gwendolyn Becher, Leighton Joshi, Medha Prozialeck, Walter Lamar, Peter Lodise, Thomas P Scheetz, Marc H 1419. 24-Hour Pharmacokinetic Relationships for Intravenous Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury |
title | 1419. 24-Hour Pharmacokinetic Relationships for Intravenous Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury |
title_full | 1419. 24-Hour Pharmacokinetic Relationships for Intravenous Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury |
title_fullStr | 1419. 24-Hour Pharmacokinetic Relationships for Intravenous Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury |
title_full_unstemmed | 1419. 24-Hour Pharmacokinetic Relationships for Intravenous Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury |
title_short | 1419. 24-Hour Pharmacokinetic Relationships for Intravenous Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury |
title_sort | 1419. 24-hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254309/ http://dx.doi.org/10.1093/ofid/ofy210.1250 |
work_keys_str_mv | AT avedissiansean 141924hourpharmacokineticrelationshipsforintravenousvancomycinandnovelurinarybiomarkersofacutekidneyinjury AT liujiajun 141924hourpharmacokineticrelationshipsforintravenousvancomycinandnovelurinarybiomarkersofacutekidneyinjury AT odonnelljnicholas 141924hourpharmacokineticrelationshipsforintravenousvancomycinandnovelurinarybiomarkersofacutekidneyinjury AT paisgwendolyn 141924hourpharmacokineticrelationshipsforintravenousvancomycinandnovelurinarybiomarkersofacutekidneyinjury AT becherleighton 141924hourpharmacokineticrelationshipsforintravenousvancomycinandnovelurinarybiomarkersofacutekidneyinjury AT joshimedha 141924hourpharmacokineticrelationshipsforintravenousvancomycinandnovelurinarybiomarkersofacutekidneyinjury AT prozialeckwalter 141924hourpharmacokineticrelationshipsforintravenousvancomycinandnovelurinarybiomarkersofacutekidneyinjury AT lamarpeter 141924hourpharmacokineticrelationshipsforintravenousvancomycinandnovelurinarybiomarkersofacutekidneyinjury AT lodisethomasp 141924hourpharmacokineticrelationshipsforintravenousvancomycinandnovelurinarybiomarkersofacutekidneyinjury AT scheetzmarch 141924hourpharmacokineticrelationshipsforintravenousvancomycinandnovelurinarybiomarkersofacutekidneyinjury |